PressReader
Catalog
For You
Category - Pfizer
New COVID-19 vaccines approved for 2026-27 to combat latest active viruses
New COVID vaccines should be available soon
New COVID vaccines should be available soon
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
FDA approves updated COVID vaccines for 2026-27 season
Updated COVID vaccines get OK
Pfizer agrees to settlement deal over drug Chantix
Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
Pfizer beats earnings estimates, targets $2.5B in added cost cuts
Pfizer beats earnings estimates, targets $2.5B in more cost cuts
Drugs and Dividends
Looking at Pfizer long term
Drugs and Dividends
Arkansas lawsuit accuses drugmakers of undermining access to discount program
Would hunters take a Lyme disease vaccine? Pfizer seeks approval for one
Buckling Building Is a Warning
Buckling Building Is a Warning
N.Y. scare shows challenge of turning offices to housing
Neighborhood News
N.Y. construction scare highlights the challenges of office conversions
N.Y. construction scare highlights the challenges of office conversions
New York construction scare highlights challenges
New York City construction scare highlights challenges